FBT.L vs. XLVP.L
FBT.L (First Trust NYSE Arca Biotechnology UCITS ETF Acc) and XLVP.L (Invesco US Health Care Sector UCITS ETF) are both Health & Biotech Equities funds - FBT.L tracks the NASDAQ Biotechnology TR USD while XLVP.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, FBT.L returned 7.17%/yr vs 6.25%/yr for XLVP.L. At a 0.39 correlation, their price movements are largely independent. FBT.L charges 0.60%/yr vs 0.14%/yr for XLVP.L.
Performance
FBT.L vs. XLVP.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT.L achieves a 4.41% return, which is significantly higher than XLVP.L's -4.79% return.
FBT.L
- 1D
- 1.98%
- 1M
- 8.09%
- YTD
- 4.41%
- 6M
- 1.93%
- 1Y
- 34.35%
- 3Y*
- 9.80%
- 5Y*
- 7.17%
- 10Y*
- —
XLVP.L
- 1D
- 1.04%
- 1M
- 2.71%
- YTD
- -4.79%
- 6M
- -5.04%
- 1Y
- 13.31%
- 3Y*
- 3.13%
- 5Y*
- 6.25%
- 10Y*
- 9.76%
FBT.L vs. XLVP.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 4.41% | 17.24% | 7.13% | -0.99% | 3.88% | -2.57% | -2.54% |
XLVP.L Invesco US Health Care Sector UCITS ETF | -4.79% | 6.91% | 3.77% | -3.87% | 8.97% | 29.14% | 7.98% |
Correlation
The correlation between FBT.L and XLVP.L is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.39 |
Over the past year, FBT.L and XLVP.L have become more correlated (0.64) than their long-term average of 0.39, meaning their price movements have been converging.
FBT.L vs. XLVP.L - Sectors Allocation Comparison
Sectors
FBT.L
XLVP.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT.L
XLVP.L
Basic Materials
FBT.L
-
XLVP.L
-
Communication Services
FBT.L
-
XLVP.L
-
Consumer Cyclical
FBT.L
-
XLVP.L
-
Consumer Defensive
FBT.L
-
XLVP.L
-
Energy
FBT.L
-
XLVP.L
-
Financial Services
FBT.L
-
XLVP.L
-
Industrials
FBT.L
-
XLVP.L
-
Real Estate
FBT.L
-
XLVP.L
-
Technology
FBT.L
-
XLVP.L
-
Utilities
FBT.L
-
XLVP.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT.L vs. XLVP.L — Risk / Return Rank
FBT.L
XLVP.L
FBT.L vs. XLVP.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and Invesco US Health Care Sector UCITS ETF (XLVP.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT.L | XLVP.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.16 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 2.48 | 1.15 | +1.33 |
| Martin ratioReturn relative to average drawdown | 6.60 | 2.91 | +3.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT.L | XLVP.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.70 | 0.92 | +0.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.44 | +0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.62 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.69 | -0.43 |
Drawdowns
FBT.L vs. XLVP.L - Drawdown Comparison
The maximum FBT.L drawdown since its inception was -30.39%, which is greater than XLVP.L's maximum drawdown of -19.67%. Use the drawdown chart below to compare losses from any high point for FBT.L and XLVP.L.
Loading charts...
Drawdown Indicators
| FBT.L | XLVP.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.39% | -19.67% | -10.72% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -11.56% | -2.25% |
Max Drawdown (3Y)Largest decline over 3 years | -23.70% | -19.67% | -4.03% |
Max Drawdown (5Y)Largest decline over 5 years | -23.70% | -19.67% | -4.03% |
Max Drawdown (10Y)Largest decline over 10 years | — | -19.67% | — |
Current DrawdownCurrent decline from peak | -1.97% | -7.82% | +5.85% |
Average DrawdownAverage peak-to-trough decline | -13.45% | -4.62% | -8.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.19% | 4.56% | +0.63% |
Volatility
FBT.L vs. XLVP.L - Volatility Comparison
First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a higher volatility of 6.10% compared to Invesco US Health Care Sector UCITS ETF (XLVP.L) at 4.59%. This indicates that FBT.L's price experiences larger fluctuations and is considered to be riskier than XLVP.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT.L | XLVP.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 4.59% | +1.51% |
Volatility (6M)Calculated over the trailing 6-month period | 15.02% | 10.09% | +4.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.11% | 14.47% | +5.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.49% | 14.19% | +8.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.86% | 15.82% | +8.04% |
FBT.L vs. XLVP.L - Expense Ratio Comparison
FBT.L has a 0.60% expense ratio, which is higher than XLVP.L's 0.14% expense ratio.
Dividends
FBT.L vs. XLVP.L - Dividend Comparison
Neither FBT.L nor XLVP.L has paid dividends to shareholders.
Frequently Asked Questions
FBT.L and XLVP.L have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVP.L is cheaper at 0.14% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVP.L is cheaper with a 0.14% expense ratio, compared with 0.60% for FBT.L.
FBT.L tracks NASDAQ Biotechnology TR USD, while XLVP.L tracks MSCI World/Health Care NR USD. They also come from different issuers: First Trust and Invesco. Their fees differ too: 0.60% for FBT.L and 0.14% for XLVP.L.
Find the right allocation for FBT.L and XLVP.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer